Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Eurofins-Cerep's Days Inventory or its related term are showing as below:
XPAR:ALECR'
s Days Inventory Range Over the Past 10 Years
Min: 40.12 Med: 46.42 Max: 60.65
Current: 58.62
During the past 13 years, Eurofins-Cerep's highest Days Inventory was 60.65. The lowest was 40.12. And the median was 46.42.
XPAR:ALECR's Days Inventory is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 67.64
vs XPAR:ALECR: 58.62
Eurofins-Cerep's Days Inventory
declined
from Dec. 2024 (61.87) to Dec. 2025 (58.67).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Eurofins-Cerep's Inventory Turnover for the
six
months ended in Dec. 2025 was 3.11.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Eurofins-Cerep's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.13.
Eurofins-Cerep (XPAR:ALECR) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Eurofins-Cerep's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Eurofins-Cerep's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Eurofins-Cerep Days Inventory Related Terms
Eurofins-Cerep Days Inventory Historical Data
* Premium members only.
The historical data trend for Eurofins-Cerep's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:ALECR vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, Eurofins-Cerep's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eurofins-Cerep Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins-Cerep's Days Inventory distribution charts can be found below:
* The bar in red indicates where Eurofins-Cerep's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eurofins-Cerep (XPAR:ALECR) has a Days Inventory of 58.67 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Eurofins-Cerep and its competitors. This is 26% above median its historical median of 46.42. Over the past decade, Eurofins-Cerep's Days Inventory has ranged from 40.12 to 60.65.
Is Eurofins-Cerep's Days Inventory too high?
Eurofins-Cerep's current Days Inventory of 58.67 is 26% above median its 10-year median of 46.42. Over the past 10 years, this metric has ranged from a low of 40.12 to a high of 60.65. The Medical Diagnostics & Research industry median Days Inventory is 67.64. Eurofins-Cerep's value of 58.67 is 13.3% below this industry median. Overall, Eurofins-Cerep has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Eurofins-Cerep's Days Inventory compare to TMO and DHR?
Eurofins-Cerep's Days Inventory of 58.67 can be compared against companies in the Medical Diagnostics & Research industry. The industry median Days Inventory is 67.64. Eurofins-Cerep's value of 58.67 is 13.3% below this benchmark. Historically, Eurofins-Cerep's own Days Inventory has ranged from 40.12 to 60.65 over the past decade. While the company's 10-year median is 46.42 vs. the industry median of 67.64, Eurofins-Cerep has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 67.64, based on 177 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eurofins-Cerep's current Days Inventory of 58.67 is 13.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Eurofins-Cerep and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 67.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eurofins-Cerep's current Days Inventory is 58.67, which is 26% above median its own 10-year median of 46.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurofins-Cerep stock overvalued right now?
Eurofins-Cerep (XPAR:ALECR) has a current Days Inventory of 58.67. The stock's GF Value™ is €20,317.48, compared to a current price of €16,300.00 — trading 19.8% below its estimated fair value. The current Days Inventory is 58.67, which is 26% above median its 10-year median of 46.42 and 13.3% below the Medical Diagnostics & Research industry median of 67.64. Eurofins-Cerep's overall GF Score™ is 27/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Eurofins-Cerep (XPAR:ALECR), the current Days Inventory is 58.67 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eurofins-Cerep (XPAR:ALECR) Overvalued in 2026?
Based on GuruFocus' analysis, Eurofins-Cerep stock appears to be undervalued.
The current stock price of €16,300.00 is trading 19.8% below its estimated GF Value™ of €20,317.48.
Key valuation signals for XPAR:ALECR:
Days Inventory: 58.67 (26% above median its 10-year median of 46.42)
GF Value™: €20,317.48 vs. price of €16,300.00 (19.8% below fair value)
Industry Position: 13.3% below the Medical Diagnostics & Research median
No single metric tells the full story. See the XPAR:ALECR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eurofins-Cerep SA provides in vitro pharmacology, in vitro ADME-Tox and in vivo PK services and solutions. The company also offers cost-effective drug discovery by identifying at early stages drug candidates and eliminating them. Some solutions provided by the company are - compound management, high-throughout screening, in vitro safety profiling, lead optimization profiling, in vitro ADME profiling, and in vivo PK.
27GF Score
Get the complete analysis for XPAR:ALECR
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:ALECR has been successfully added to your 
